MENU
RARE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ultragenyx Pharmaceutical (RARE) Ownership - Who owns Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.8B
P/E Ratio
N/A
Total Cash
477.39M
Projected Growth
N/A
Total Debt
36.3M
Revenue
610.16M
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash/Share
4.95
Total Debt/Equity
N/A
Revenue/Share
6.32 USD as % of share price
Fundamentals
RARE
Capitalization
2.8B
P/E Ratio
N/A
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash
477M
Total Cash/Share
4.95
Total Debt
36.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.32%
Revenue
610M
ROE
N/A
Book Value
151M
P/B Ratio
18.52
Cash Flow
N/A
Earnings
-5.48
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
96K
Current Ratio
2.45
Current Revenue Per Employee
128667.70
Dividends Per Share - Security
N/A
EBITDA
-435.33M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.18
Revenue To Assets
-36.44
Shares Held By Institutions
10.4B
Shares Outstanding - Current
96.4M
Total Liabilities
1.15B
Total Volume MTD
N/A
Value
-1
Gain YTD
-30.877
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RARE showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of therapeutics for rare diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
60 Leveroni Court
Phone
+1 415 483-8800
Employees
1276
Web
https://www.ultragenyx.com